Screener / SEC EDGAR /CIK 0001736297 /10-K filed Feb 20, 2026, compared with Feb 14, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Semiconductors

Astera Labs, Inc. ALAB

Compare with peers Embed
Earnings releases

Latest results release: Nov 3, 2026

8-K item 2.02, exhibit 99

What ALAB's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Nov 3, 2026, ALAB reported $0.99 per share under GAAP and $1.32 on its own adjusted basis: the adjusted number is +33% above GAAP.

GAAP EPS $-0.05, release Aug 6, 2024: GAAP diluted net loss per share of $0.05 Non-GAAP Financial Results (excluding the impact of stock-based compensation expense and the income tax effects of non-GAAP adjustments): Adjusted EPS $0.13, release Aug 6, 2024: Non-GAAP diluted earnings per share of $0.13 Second Quarter of Fiscal 2024 and Recent Business Highlights 2024-08 GAAP EPS $-0.05, release Nov 4, 2024: GAAP diluted net loss per share of $0.05 Non-GAAP Financial Results (excluding the impact of stock-based compensation expense and the income tax effects of non-GAAP adjustments): Adjusted EPS $0.23, release Nov 4, 2024: Non-GAAP diluted earnings per share of $0.23 Third Quarter of Fiscal 2024 and Recent Business Highlights 2024-11 GAAP EPS $0.83, release Aug 4, 2026: GAAP diluted net income per share of $0.83 Non-GAAP Financial Results (1) : Adjusted EPS $0.80, release Aug 4, 2026: Non-GAAP diluted net income per share of $0.80 ____________ (1) See “Reconciliation of GAAP to Non-GAAP Financial Measures” table included below. -4% 2026-08 GAAP EPS $0.99, release Nov 3, 2026: GAAP diluted net income per share of $0.99 Non-GAAP Financial Results (1) : Adjusted EPS $1.32, release Nov 3, 2026: Non-GAAP diluted net income per share of $1.32 ____________ (1) See “Reconciliation of GAAP to Non-GAAP Financial Measures” table included below. +33% 2026-11
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
ReleaseGAAP EPSAdjusted EPSGap
Nov 3, 2026 0.99 1.32 +33%
Aug 4, 2026 0.83 0.80 -4%
Nov 4, 2024 -0.05 0.23 –
Aug 6, 2024 -0.05 0.13 –
The company's words, latest release
GAAP diluted net income per share of $0.99 Non-GAAP Financial Results (1) : release
Non-GAAP diluted net income per share of $1.32 ____________ (1) See “Reconciliation of GAAP to Non-GAAP Financial Measures” table included below. release

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 3, 2026 · EX-99.1

[email protected]

Open on SEC

• Record quarterly revenue of $584.9 million, up 49% QoQ and up 154% year-over- year

• Scorpio™ fabric switches became the company's largest product family, led by volume production of the Scorpio X-Series 320-lane fabric switch

• Portfolio expanded across memory, optical and copper signal conditioning, and rack-scale AI platforms with Leo 2 and Leo X-Series, Aries 7 and Orion

– Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced financial results for the third quarter of fiscal year 2026, ended September 30, 2026.

“Astera Labs delivered outstanding Q3 2026 results, with record quarterly revenue of $584.9 million, up 49% sequentially and up 154% year-over-year, with broad-based growth led by Scorpio, which ramped to high-volume production and became our largest product family by revenue,” said Jitendra Mohan, Astera Labs’ Chief Executive Officer. “Design activity accelerated with wins across a broad set of programs and applications at multiple customers. We expanded our portfolio with the introduction of Aries 7 for optical and copper signal conditioning, Leo 2 and Leo X-Series for AI and general-purpose memory expansion, and Orion rack-scale reference architecture. The expansion of our intelligent connectivity platform and new design wins position us to strongly grow our dollar content per accelerator and further increase our total market opportunity.”

(1) See “Reconciliation of GAAP to Non-GAAP Financial Measures” table included below.

• Announced Aries 7, the industry’s first and broadest PCIe® 7 signal conditioning portfolio, spanning Smart Retimers, Smart Redrivers, Smart Cable Modules, Smart Optical Drivers, and Smart Optical Transimpedance Amplifiers (TIAs). The expanded portfolio extends reach from centimeters of PCB trace to 50+ meters over optical cables spanning multiple racks and includes optical connectivity solutions purpose-built for near-packaged optics (NPO) and linear pluggable optics (LPO) applications. Aries 7 Smart Retimers and Smart Redrivers support the OCP Signal Conditioner Standard Footprint, allowing customers to select different signal conditioners without redesigning the board. Aries 7 products are expected to begin sampling in Q4 2026 to select hyperscale, OEM, and NPO customers.

• Unveiled Orion, a compute-agnostic rack-scale reference architecture that allows customers to choose their own GPU and CPU. Orion comprises six production-grade reference designs—spanning rack, compute tray, fabric tray, memory tray, link board, and compute board—and its high-radix 320-lane PCIe switch fabric is designed to scale from 8 to 160 accelerators per pod while helping the same accelerator extract more tokens per second across AI inference workloads. All designs are integrated with COSMOS Rack Manager and COSMOS Fabric Manager orchestration software for management, fleet-wide telemetry and diagnostics. Orion is designed primarily for neocloud and enterprise customers building AI inference capacity, and rack reference and system designs are on track for availability through Astera Labs’ OEM and ODM partners beginning in Q1 2027.

• Expanded the Leo Smart Memory Controller™ family with three new memory connectivity solutions—Leo X-Series and the Leo 2 E-Series and P-Series—extending the portfolio across direct fabric-attached GPU memory, CPU- attached expansion, and pooled memory architectures. Paired with Scorpio X-Series Fabric Switches, Leo X-Series enables fabric-attached memory for long- context, KV-cache-intensive workloads, improving inference performance with up to 62% faster time-to-first-token and up to 22% more tokens per second (as measured by the company’s internal testing). The new Leo 2 E-Series and P-Series support CPU-attached DDR4 and DDR5 memory expansion with PCIe® 6 and CXL® 3.2 support, and double memory bandwidth and capacity versus the previous generation.

• Showcased the expanded Aries and Orion families at the 2026 Open Compute Project (OCP) Global Summit in San Jose, including a powered Orion rack featuring interchangeable, pre-validated compute trays with different CPU and accelerator configurations and live demonstrations of the Scorpio X-Series 320-lane Smart Fabric Switch with Hypercast™ and In-Network Compute, the Leo X-Series Smart Memory Controller, and PCIe 7 copper and optical signal conditioning.

Based on current business trends and conditions, Astera Labs estimates the following:

• GAAP operating expenses within a range of approximately $273 million to $279 million

• GAAP diluted net income per share of approximately $1.13 to $1.17 on weighted- average diluted shares outstanding of approximately 187 million

• Non-GAAP operating expenses within a range of approximately $194 million to $200 million

• Non-GAAP dilu ted net income per share of approximately $1.62 to $1.66 on weighted-average diluted shares outstanding of approximately 187 million

Astera Labs will host a conference call to review its financial results for the third quarter of 2026 and to discuss its financial outlook today at 1:30 p.m. Pacific Time. Interested parties may join the conference call by dialing 1-833-461-5787 and using conference ID 751 181 378. The call will also be webcast and can be accessed at the Astera Labs website at https://ir.asteralabs.com/. The webcast will be recorded and available for replay on the company’s website for the next six months.

We use certain non-GAAP financial measures, including those concerning our financial outlook, to supplement the performance measures in our consolidated financial statements, which are presented in accordance with GAAP. A reconciliation of these non-GAAP measures to the closest GAAP measures can be found later in this release. The timing and impact of any adjustments to arrive at the corresponding GAAP financial measures concerning our financial outlook are inherently dependent on future events that are typically uncertain or that may be outside of our control. These non-GAAP financial measures include non- GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP tax rate, non-GAAP net income, and non-GAAP diluted net income per share. We use these non-GAAP financial measures for financial and operational decision-making and as a means to assist us in evaluating period-to-period comparisons. By excluding certain items that may not be indicative of our recurring core operating results, we believe that non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP tax rate, non-GAAP net income, and non-GAAP diluted net income per share provide meaningful supplemental information regarding our performance. Accordingly, we believe these non-GAAP financial measures are useful to investors and others because they allow for additional information with respect to financial measures used by management in its financial and operational decision-making and they may be used by our institutional investors and the analyst community to help them analyze the health of our business. However, there are a number of limitations related to the use of non-GAAP financial measures, and these non-GAAP measures should be considered in addition to, not as a substitute for or in isolation from, our financial results prepared in accordance with GAAP. Other companies, including companies in our industry, may calculate these non-GAAP financial measures differently or not at all, which reduces their usefulness as comparative measures.

We adjust the following items from one or more of our non-GAAP financial measures:

We exclude non-cash stock-based compensation expense from certain of our non- GAAP financial measures because we believe that excluding this item provides meaningful supplemental information regarding operational performance. In particular, companies calculate non-cash stock-based compensation expense using a variety of valuation methodologies and subjective assumptions. Moreover, stock-based compensation expense is a non-cash charge that can vary significantly from period to period for reasons that are unrelated to our core operating performance, and therefore excluding this item provides investors and other users of our financial information with information that allows meaningful comparisons of our business performance across periods.

We exclude acquisition-related costs incurred in connection with our acquisitions, which we generally would not have otherwise incurred in the periods presented as part of our continuing operations. Acquisition-related costs include certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees. We believe that providing the non-GAAP measures excluding these costs assists our investors because such costs are not reflective of our ongoing operating results.

We exclude other adjustments, including non-cash fair value adjustments related to equity investments without readily determinable fair values. These investments are measured at cost and adjusted for observable price changes or impairment on a nonrecurring basis only upon the occurrence of certain events. Accordingly, these adjustments are not indicative of our core operating performance.

This represents the impact of the non-GAAP adjustments on an after-tax basis and one-off discrete tax adjustments that are unrelated to our core operating performance in connection with the presentation of non-GAAP net income and non- GAAP diluted net income per share. This approach is designed to enhance investors’ ability to understand the impact of our non-GAAP tax expense on our current operations, provide improved modeling accuracy, and substantially reduce fluctuations caused by GAAP to non-GAAP adjustments.

This press release and the accompanying oral presentation contain forward- looking statements based on Astera Labs' current expectations. The words “accelerating,” “advance,” “ahead,” “aim,” “anticipate,” “beginning,” “believe,” “built to,” “can,” “capabilities,” “coming,” “commence,” “committed,” “confidence,” “continue,” “could,” “deliver,” “designed,” “drive,” “early stages,” “enable,” “estimates," “expanding,” “expect," “forecasting,” “forthcoming,” “forward,” “future,” “goal,” “going forward,” “growth,” “guidance,” “intend," “interest,” “journey,” “long-term,” “look,” “may,” “mission,” “momentum,” “multi-year,” “next,” “on track,” “opportunity,” “outlook,” “paths,” “plan,” “poised,” “position,” “potential,” “progressing,” “project,” “proliferate,” “proposed,” “prospects,” “provide,” “pursuing,” “ramp,” “represent,” “roadmap,” “should,” “strategy,” “targeted,” “track,” “trajectory,” “trends,” “upcoming,” “upside,” “ultimately,” “vectors,” “vision,” “well positioned,” “will,” “would,” and similar phrases as they relate to Astera Labs, as well as any references to future periods, are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Astera Labs as of November 3, 2026, and are subject to various assumptions, beliefs, risks and uncertainties that could cause actual results to differ materially from expectations. These forward-looking statements include, but are not limited to, statements regarding market trends, dynamics and expectations (including cloud and AI infrastructure and connectivity market trends and the industry’s build-out); our and our ultimate customers’ future demand, product purchases, deployment of systems incorporating our products, business, operating results, cash flow, financial position, outlook and guidance (and any underlying drivers), including for the fourth quarter of fiscal 2026; our business strategy, plans and market, revenue or other forms of opportunities, our absolute or relative market share or growth profile or rate and our timing, diversification and ability to further build upon our revenue base, expand our product offerings, portfolio and features or performance, increase and service our market opportunity (including the timing and extent of such market opportunities), remain at the forefront of an AI infrastructure transformation, and scale or expand our connectivity platform; our objectives or strategies for future operations (such as our optical, custom solutions and rack-scale platform businesses), organizational investments and changes, and the drivers, timing and impacts associated therewith; our pre-production, production, development, shipping/shipments and delivery of (including timing and customers), activity, applications and demand for, availability of, as well as absolute and relative revenue, growth (including the drivers), pricing, ramping and

roadmap (e.g., optical, Leo and Orion) for, existing, new, growing or enhanced (whether technologically or otherwise) products or software, including the high volume deployment of Scorpio X-Series solutions, the expansion of our Scorpio P-Series customer base, the sampling and availability of our Aries 7 portfolio, the availability of Orion rack reference and system designs through our OEM and ODM partners, the adoption of our expanded Leo portfolio, and additional growth catalysts across our Scorpio, Aries, Taurus and Leo portfolios, and the comparative capabilities, performance and results of those products or software for our customers; the benefits, timing, impact, proliferation and customer adoption of different connectivity standards and demands; the design wins at and diversification, activity, engagements and expectations of our customers; the plans and potential success of our announced and ongoing collaborations, partnerships and strategic relationships, including our warrant agreement with Amazon and our collaborations with AMD, Intel and NVIDIA; the ability of UALink 2.0 to provide for a purpose-built AI compute fabric capable of scaling with industry needs over time and the timing of any initial programs; our competitive positioning and the impacts thereof; our research and development, technology and strategic IP plans; the strategies associated with, investments in and size of our team, as well as the associated impacts; and future industry and macroeconomic conditions, events and trends such as in cloud and AI infrastructure as well as our preparedness and solutions for them.

A variety of risks and factors that are beyond our control could cause actual results to differ materially from those in the forward-looking statements including, without limitation: the competitive and cyclical nature of the semiconductor industry; the concentration of our customer base; the changes in demand for AI; the macroeconomic and/or geopolitical environment, including economic uncertainty and volatility in the capital markets; risks that demand for our products and the supply chain may be adversely affected, including by the imposition of tariffs by the United States or any other jurisdiction and any corresponding retaliatory tariffs, changes in political policies, military conflict (such as between Russia/Ukraine and in Israel, Iran and the Middle East), terrorism, sanctions or other geopolitical events globally (including conflict between Taiwan and China); quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with managing international activities (including trade barriers, particularly with respect to China); our ability to successfully complete acquisitions and to integrate newly acquired businesses and offerings; absence of long-term commitments from customers; risks that Astera Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; stock price volatility; information technology risks, including cybersecurity risks such as cyber-attacks against Astera Labs' products and its networks; and other risks and uncertainties that are detailed under the caption “Risk Factors” and elsewhere in our Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission (“SEC”) on February 20, 2026, and in subsequent Quarterly Reports on Form 10-Q filed with the SEC and the other SEC filings and reports Astera Labs may make from time to time. Moreover, we operate in a very competitive and rapidly changing environment, and new risks may emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor(s) may cause actual results or outcomes to differ materially from those contained in any forward-looking statements we may make. Accordingly, you should not unduly rely on any of the forward-looking statements. Astera Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Astera Labs (Nasdaq: ALAB) provides rack-scale AI infrastructure through purpose-built connectivity solutions. By collaborating with hyperscalers and ecosystem partners, Astera Labs enables organizations to unlock the full potential of modern AI. Astera Labs' Intelligent Connectivity Platform integrates CXL®, Ethernet, NVLink Fusion, PCIe®, and UALink™ semiconductor-based technologies with the company's COSMOS software suite to unify diverse components into cohesive, flexible systems that deliver end-to-end scale-up and scale-out connectivity. The company's custom connectivity solutions business complements its standards-based portfolio, enabling customers to deploy tailored architectures to meet their unique infrastructure requirements. Discover more at www.asteralabs.com.

September 30, December 31, As of 2026 2025 ────────────────────────────────────────────────────────────────────────────── Assets Current assets Cash and cash equivalents $ 209,396 $ 167,611 Marketable securities 1,168,847 1,021,205 Accounts receivable, net 284,253 83,202 Inventory 200,893 58,979 Prepaid expenses and other current 91,830 31,033 assets Total current assets 1,955,219 1,362,030 Property and equipment, net 170,713 92,038 Goodwill 91,557 19,015 Other assets 82,844 58,740 Total assets $ 2,300,333 $ 1,531,823 Liabilities and Stockholders’ Equity Current liabilities Accounts payable $ 96,828 $ 42,362 Accrued expenses and other current 146,752 90,680 liabilities Total current liabilities 243,580 133,042 Other liabilities 57,285 35,147 Total liabilities 300,865 168,189 Stockholders’ equity Common stock 17 17 Additional paid-in capital 1,585,959 1,348,969 Accumulated other comprehensive (loss) -13,188 4,310 income Retained earnings 426,680 10,338 Total stockholders’ equity 1,999,468 1,363,634 Total liabilities and stockholders’ $ 2,300,333 $ 1,531,823 equity

Cash flows from operating Nine Months Ended activities September 30, 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 416,342 $ 174,152 Adjustments to reconcile net income to net cash provided by operating activities Stock-based 195,495 118,659 compensation Depreciation and 12,681 3,983 amortization Warrants contra 30,397 4,016 revenue Accretion of discounts on -3,426 -6,278 marketable securities Other, net 7,312 2,521 Changes in operating assets and liabilities: Accounts -201,245 -4,089 receivable, net Inventory -146,173 -7,106 Prepaid expenses -51,767 -56,760 and other assets Accounts payable 38,814 -1,088 Accrued expenses and other 43,047 -3,969 liabilities Net cash provided by operating 341,477 224,041 activities Cash flows from investing activities Purchases of property and -73,363 -18,855 equipment Purchases of marketable -509,927 -664,432 securities Sales and maturities of 348,213 515,109 marketable securities Payments for business -69,214 — combinations, net of cash acquired Other investing -2,500 -500 activities Net cash used in investing -306,791 -168,678 activities Cash flows from financing activities Proceeds from exercises of stock 802 1,730 options Proceeds from employee stock 6,294 4,345 purchase plan Net cash provided by financing 7,096 6,075 activities Net increase in cash, cash 41,782 61,438 equivalents, and restricted cash Cash, cash equivalents, and restricted cash Beginning of the 167,684 80,044 period End of the period $ 209,466 $ 141,482

(2 ) Acquisition-related costs included certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees.

(3) Other included non-cash and nonrecurring fair value adjustments on equity investments without readily determinable fair values.

(4) Income tax effect is calculated based on the tax laws in the jurisdictions in which we operate and is calculated to exclude the impact of stock-based compensation expense and one-off discrete tax adjustments that are unrelated to our core operating performance. For the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, the non-GAAP tax rate was approximately 11%, 12%, and 18%, respectively. For the nine months ended September, 2026 and 2025, the non-GAAP tax rate was approximately 11% and 12%, respectively.

Outlook for Three Months Ending December 31, 2026 ────────────────────────────────────────────────────────────────────────────── Low High GAAP gross margin 72 % 72 % Stock-basedcompensati… — — Non-GAAP gross margin 72 % 72 % GAAP operating $ 273 $ 279 expenses Stock-based -79 -79 compensation expense Non-GAAP operating $ 194 $ 200 expenses GAAP tax rate 20 % 20 % Income tax effect -8 -8 Non-GAAP tax rate 12 % 12 % GAAP net income per $ 1.13 $ 1.17 share - diluted Stock-based 0.43 0.43 compensation expense Income tax effect 0.06 0.06 Non-GAAP net income $ 1.62 $ 1.66 per share - diluted

Full text with the tables
                                                                    Exhibit 99.1
                                                                                
                                                        IR CONTACT: Leslie Green
                                                                                
                                                     [email protected]
                                                                                
            Astera Labs Reports Third Quarter 2026 Financial Results            
                                                                                
• Record quarterly revenue of $584.9 million, up 49% QoQ and up 154% year-over-
year

• Scorpio™ fabric switches became the company's largest product family, led by
volume production of the Scorpio X-Series 320-lane fabric switch

• Portfolio expanded across memory, optical and copper signal conditioning, and
rack-scale AI platforms with Leo 2 and Leo X-Series, Aries 7 and Orion
                                                                                
  SAN JOSE,                                                                     
                                                                                
                                                                                
  CA, U.S. – November 3, 2026                                                   
                                                                                
– Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity
solutions for rack-scale AI infrastructure, today announced financial results
for the third quarter of fiscal year 2026, ended September 30, 2026.

“Astera Labs delivered outstanding Q3 2026 results, with record quarterly
revenue of $584.9 million, up 49% sequentially and up 154% year-over-year, with
broad-based growth led by Scorpio, which ramped to high-volume production and
became our largest product family by revenue,” said Jitendra Mohan, Astera Labs’
Chief Executive Officer. “Design activity accelerated with wins across a broad
set of programs and applications at multiple customers. We expanded our
portfolio with the introduction of Aries 7 for optical and copper signal
conditioning, Leo 2 and Leo X-Series for AI and general-purpose memory
expansion, and Orion rack-scale reference architecture. The expansion of our
intelligent connectivity platform and new design wins position us to strongly
grow our dollar content per accelerator and further increase our total market
opportunity.”
                                                                                
  Third Quarter of Fiscal 2026 Financial Highlights                             
                                                                                
GAAP Financial Results:

• Revenue of $584.9 million, up 49% sequentially and up 154% year-over-year

• GAAP gross margin of 72.3%

• GAAP operating income of $179.1 million

• GAAP operating margin of 30.6%

• GAAP net income of $182.9 million

• GAAP diluted net income per share of $0.99

Non-GAAP Financial Results (1) :

• Non-GAAP gross margin of 72.4%

• Non-GAAP operating income of $261.6 million

• Non-GAAP operating margin of 44.7%

• Non-GAAP net income of $243.4 million

• Non-GAAP diluted net income per share of $1.32

____________

(1) See “Reconciliation of GAAP to Non-GAAP Financial Measures” table included
below.
                                                                                
  Q3 2026 and Recent Business Highlights                                        
                                                                                
• Announced Aries 7, the industry’s first and broadest PCIe® 7 signal
conditioning portfolio, spanning Smart Retimers, Smart Redrivers, Smart Cable
Modules, Smart Optical Drivers, and Smart Optical Transimpedance Amplifiers
(TIAs). The expanded portfolio extends reach from centimeters of PCB trace to
50+ meters over optical cables spanning multiple racks and includes optical
connectivity solutions purpose-built for near-packaged optics (NPO) and linear
pluggable optics (LPO) applications. Aries 7 Smart Retimers and Smart Redrivers
support the OCP Signal Conditioner Standard Footprint, allowing customers to
select different signal conditioners without redesigning the board. Aries 7
products are expected to begin sampling in Q4 2026 to select hyperscale, OEM,
and NPO customers.

• Unveiled Orion, a compute-agnostic rack-scale reference architecture that
allows customers to choose their own GPU and CPU. Orion comprises six
production-grade reference designs—spanning rack, compute tray, fabric tray,
memory tray, link board, and compute board—and its high-radix 320-lane PCIe
switch fabric is designed to scale from 8 to 160 accelerators per pod while
helping the same accelerator extract more tokens per second across AI inference
workloads. All designs are integrated with COSMOS Rack Manager and COSMOS Fabric
Manager orchestration software for management, fleet-wide telemetry and
diagnostics. Orion is designed primarily for neocloud and enterprise customers
building AI inference capacity, and rack reference and system designs are on
track for availability through Astera Labs’ OEM and ODM partners beginning in Q1
2027.

• Expanded the Leo Smart Memory Controller™ family with three new memory
connectivity solutions—Leo X-Series and the Leo 2 E-Series and
P-Series—extending the portfolio across direct fabric-attached GPU memory, CPU-
attached expansion, and pooled memory architectures. Paired with Scorpio
X-Series Fabric Switches, Leo X-Series enables fabric-attached memory for long-
context, KV-cache-intensive workloads, improving inference performance with up
to 62% faster time-to-first-token and up to 22% more tokens per second (as
measured by the company’s internal testing). The new Leo 2 E-Series and P-Series
support CPU-attached DDR4 and DDR5 memory expansion with PCIe® 6 and CXL® 3.2
support, and double memory bandwidth and capacity versus the previous
generation.

• Showcased the expanded Aries and Orion families at the 2026 Open Compute
Project (OCP) Global Summit in San Jose, including a powered Orion rack
featuring interchangeable, pre-validated compute trays with different CPU and
accelerator configurations and live demonstrations of the Scorpio X-Series
320-lane Smart Fabric Switch with Hypercast™ and In-Network Compute, the Leo
X-Series Smart Memory Controller, and PCIe 7 copper and optical signal
conditioning.
                                                                                
  Fourth Quarter of Fiscal 2026 Financial Outlook                               
                                                                                
Based on current business trends and conditions, Astera Labs estimates the
following:

GAAP Financial Outlook:

• Revenue within a range of $730 million to $750 million

• GAAP gross margin of approximately 72%

• GAAP operating expenses within a range of approximately $273 million to $279
million

• GAAP tax rate of approximately 20%

• GAAP diluted net income per share of approximately $1.13 to $1.17 on weighted-
average diluted shares outstanding of approximately 187 million

Non-GAAP Financial Outlook (2) :

• Non-GAAP gross margin of approximately 72%

• Non-GAAP operating expenses within a range of approximately $194 million to
$200 million

• Non-GAAP tax rate of approximately 12%

• Non-GAAP dilu ted net income per share of approximately $1.62 to $1.66 on
weighted-average diluted shares outstanding of approximately 187 million

_____________

(2) See “Reconciliation of GAAP to Non-GAAP Outlook” table included below.
                                                                                
  Earnings Webcast and Conference Call                                          
                                                                                
Astera Labs will host a conference call to review its financial results for the
third quarter of 2026 and to discuss its financial outlook today at 1:30 p.m.
Pacific Time. Interested parties may join the conference call by dialing
1-833-461-5787 and using conference ID 751 181 378. The call will also be
webcast and can be accessed at the Astera Labs website at
https://ir.asteralabs.com/. The webcast will be recorded and available for
replay on the company’s website for the next six months.
                                                                                
  Discussion of Non-GAAP Financial Measures                                     
                                                                                
We use certain non-GAAP financial measures, including those concerning our
financial outlook, to supplement the performance measures in our consolidated
financial statements, which are presented in accordance with GAAP. A
reconciliation of these non-GAAP measures to the closest GAAP measures can be
found later in this release. The timing and impact of any adjustments to arrive
at the corresponding GAAP financial measures concerning our financial outlook
are inherently dependent on future events that are typically uncertain or that
may be outside of our control. These non-GAAP financial measures include non-
GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP
operating income, non-GAAP operating margin, non-GAAP tax rate, non-GAAP net
income, and non-GAAP diluted net income per share. We use these non-GAAP
financial measures for financial and operational decision-making and as a means
to assist us in evaluating period-to-period comparisons. By excluding certain
items that may not be indicative of our recurring core operating results, we
believe that non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating
expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP tax
rate, non-GAAP net income, and non-GAAP diluted net income per share provide
meaningful supplemental information regarding our performance. Accordingly, we
believe these non-GAAP financial measures are useful to investors and others
because they allow for additional information with respect to financial measures
used by management in its financial and operational decision-making and they may
be used by our institutional investors and the analyst community to help them
analyze the health of our business. However, there are a number of limitations
related to the use of non-GAAP financial measures, and these non-GAAP measures
should be considered in addition to, not as a substitute for or in isolation
from, our financial results prepared in accordance with GAAP. Other companies,
including companies in our industry, may calculate these non-GAAP financial
measures differently or not at all, which reduces their usefulness as
comparative measures.

We adjust the following items from one or more of our non-GAAP financial
measures:

Stock-based compensation expense

We exclude non-cash stock-based compensation expense from certain of our non-
GAAP financial measures because we believe that excluding this item provides
meaningful supplemental information regarding operational performance. In
particular, companies calculate non-cash stock-based compensation expense using
a variety of valuation methodologies and subjective assumptions. Moreover,
stock-based compensation expense is a non-cash charge that can vary
significantly from period to period for reasons that are unrelated to our core
operating performance, and therefore excluding this item provides investors and
other users of our financial information with information that allows meaningful
comparisons of our business performance across periods.

Acquisition-related costs

We exclude acquisition-related costs incurred in connection with our
acquisitions, which we generally would not have otherwise incurred in the
periods presented as part of our continuing operations. Acquisition-related
costs include certain incremental expenses incurred to effect a business
combination such as third-party costs: advisory, legal, accounting, valuation,
and other professional fees. We believe that providing the non-GAAP measures
excluding these costs assists our investors because such costs are not
reflective of our ongoing operating results.

Other

We exclude other adjustments, including non-cash fair value adjustments related
to equity investments without readily determinable fair values. These
investments are measured at cost and adjusted for observable price changes or
impairment on a nonrecurring basis only upon the occurrence of certain events.
Accordingly, these adjustments are not indicative of our core operating
performance.

Income tax effect

This represents the impact of the non-GAAP adjustments on an after-tax basis and
one-off discrete tax adjustments that are unrelated to our core operating
performance in connection with the presentation of non-GAAP net income and non-
GAAP diluted net income per share. This approach is designed to enhance
investors’ ability to understand the impact of our non-GAAP tax expense on our
current operations, provide improved modeling accuracy, and substantially reduce
fluctuations caused by GAAP to non-GAAP adjustments.

Cautionary Note Regarding Forward-Looking Statements

This press release and the accompanying oral presentation contain forward-
looking statements based on Astera Labs' current expectations. The words
“accelerating,” “advance,” “ahead,” “aim,” “anticipate,” “beginning,” “believe,”
“built to,” “can,” “capabilities,” “coming,” “commence,” “committed,”
“confidence,” “continue,” “could,” “deliver,” “designed,” “drive,” “early
stages,” “enable,” “estimates," “expanding,” “expect," “forecasting,”
“forthcoming,” “forward,” “future,” “goal,” “going forward,” “growth,”
“guidance,” “intend," “interest,” “journey,” “long-term,” “look,” “may,”
“mission,” “momentum,” “multi-year,” “next,” “on track,” “opportunity,”
“outlook,” “paths,” “plan,” “poised,” “position,” “potential,” “progressing,”
“project,” “proliferate,” “proposed,” “prospects,” “provide,” “pursuing,”
“ramp,” “represent,” “roadmap,” “should,” “strategy,” “targeted,” “track,”
“trajectory,” “trends,” “upcoming,” “upside,” “ultimately,” “vectors,” “vision,”
“well positioned,” “will,” “would,” and similar phrases as they relate to Astera
Labs, as well as any references to future periods, are intended to identify such
forward-looking statements. These forward-looking statements reflect the current
views and assumptions of Astera Labs as of November 3, 2026, and are subject to
various assumptions, beliefs, risks and uncertainties that could cause actual
results to differ materially from expectations. These forward-looking statements
include, but are not limited to, statements regarding market trends, dynamics
and expectations (including cloud and AI infrastructure and connectivity market
trends and the industry’s build-out); our and our ultimate customers’ future
demand, product purchases, deployment of systems incorporating our products,
business, operating results, cash flow, financial position, outlook and guidance
(and any underlying drivers), including for the fourth quarter of fiscal 2026;
our business strategy, plans and market, revenue or other forms of
opportunities, our absolute or relative market share or growth profile or rate
and our timing, diversification and ability to further build upon our revenue
base, expand our product offerings, portfolio and features or performance,
increase and service our market opportunity (including the timing and extent of
such market opportunities), remain at the forefront of an AI infrastructure
transformation, and scale or expand our connectivity platform; our objectives or
strategies for future operations (such as our optical, custom solutions and
rack-scale platform businesses), organizational investments and changes, and the
drivers, timing and impacts associated therewith; our pre-production,
production, development, shipping/shipments and delivery of (including timing
and customers), activity, applications and demand for, availability of, as well
as absolute and relative revenue, growth (including the drivers), pricing,
ramping and

roadmap (e.g., optical, Leo and Orion) for, existing, new, growing or enhanced
(whether technologically or otherwise) products or software, including the high
volume deployment of Scorpio X-Series solutions, the expansion of our Scorpio
P-Series customer base, the sampling and availability of our Aries 7 portfolio,
the availability of Orion rack reference and system designs through our OEM and
ODM partners, the adoption of our expanded Leo portfolio, and additional growth
catalysts across our Scorpio, Aries, Taurus and Leo portfolios, and the
comparative capabilities, performance and results of those products or software
for our customers; the benefits, timing, impact, proliferation and customer
adoption of different connectivity standards and demands; the design wins at and
diversification, activity, engagements and expectations of our customers; the
plans and potential success of our announced and ongoing collaborations,
partnerships and strategic relationships, including our warrant agreement with
Amazon and our collaborations with AMD, Intel and NVIDIA; the ability of UALink
2.0 to provide for a purpose-built AI compute fabric capable of scaling with
industry needs over time and the timing of any initial programs; our competitive
positioning and the impacts thereof; our research and development, technology
and strategic IP plans; the strategies associated with, investments in and size
of our team, as well as the associated impacts; and future industry and
macroeconomic conditions, events and trends such as in cloud and AI
infrastructure as well as our preparedness and solutions for them.

A variety of risks and factors that are beyond our control could cause actual
results to differ materially from those in the forward-looking statements
including, without limitation: the competitive and cyclical nature of the
semiconductor industry; the concentration of our customer base; the changes in
demand for AI; the macroeconomic and/or geopolitical environment, including
economic uncertainty and volatility in the capital markets; risks that demand
for our products and the supply chain may be adversely affected, including by
the imposition of tariffs by the United States or any other jurisdiction and any
corresponding retaliatory tariffs, changes in political policies, military
conflict (such as between Russia/Ukraine and in Israel, Iran and the Middle
East), terrorism, sanctions or other geopolitical events globally (including
conflict between Taiwan and China); quarterly fluctuations in revenues and
operating results; difficulties developing new products that achieve market
acceptance; risks associated with managing international activities (including
trade barriers, particularly with respect to China); our ability to successfully
complete acquisitions and to integrate newly acquired businesses and offerings;
absence of long-term commitments from customers; risks that Astera Labs may not
be able to manage strains associated with its growth; credit risks associated
with its accounts receivable; stock price volatility; information technology
risks, including cybersecurity risks such as cyber-attacks against Astera Labs'
products and its networks; and other risks and uncertainties that are detailed
under the caption “Risk Factors” and elsewhere in our Annual Report on Form
10-K, filed with the U.S. Securities and Exchange Commission (“SEC”) on February
20, 2026, and in subsequent Quarterly Reports on Form 10-Q filed with the SEC
and the other SEC filings and reports Astera Labs may make from time to time.
Moreover, we operate in a very competitive and rapidly changing environment, and
new risks may emerge from time to time. It is not possible for our management to
predict all risks, nor can we assess the impact of all factors on our business
or the extent to which any factor(s) may cause actual results or outcomes to
differ materially from those contained in any forward-looking statements we may
make. Accordingly, you should not unduly rely on any of the forward-looking
statements. Astera Labs disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of new information,
future events, or otherwise, except as required by law.
                                                                                
  About Astera Labs                                                             
                                                                                
Astera Labs (Nasdaq: ALAB) provides rack-scale AI infrastructure through
purpose-built connectivity solutions. By collaborating with hyperscalers and
ecosystem partners, Astera Labs enables organizations to unlock the full
potential of modern AI. Astera Labs' Intelligent Connectivity Platform
integrates CXL®, Ethernet, NVLink Fusion, PCIe®, and UALink™ semiconductor-based
technologies with the company's COSMOS software suite to unify diverse
components into cohesive, flexible systems that deliver end-to-end scale-up and
scale-out connectivity. The company's custom connectivity solutions business
complements its standards-based portfolio, enabling customers to deploy tailored
architectures to meet their unique infrastructure requirements. Discover more at
www.asteralabs.com.
                                                                                
                               ASTERA LABS, INC.                                
                                                                                
                                                                                
               CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)                
                                                                                
                                 (In thousands)                                 
                                                                                
                                              September 30,       December 31,  
                                       As of           2026               2025  
 ────────────────────────────────────────────────────────────────────────────── 
  Assets                                                                        
  Current assets                                                                
  Cash and cash equivalents            $            209,396    $       167,611  
  Marketable securities                           1,168,847          1,021,205  
  Accounts receivable, net                          284,253             83,202  
  Inventory                                         200,893             58,979  
  Prepaid expenses and other                                                    
  current                                            91,830             31,033  
  assets                                                                        
  Total current assets                            1,955,219          1,362,030  
  Property and equipment, net                       170,713             92,038  
  Goodwill                                           91,557             19,015  
  Other assets                                       82,844             58,740  
  Total assets                         $          2,300,333    $     1,531,823  
  Liabilities and Stockholders’                                                 
  Equity                                                                        
  Current liabilities                                                           
  Accounts payable                     $             96,828    $        42,362  
  Accrued expenses and other                                                    
  current                                           146,752             90,680  
  liabilities                                                                   
  Total current liabilities                         243,580            133,042  
  Other liabilities                                  57,285             35,147  
  Total liabilities                                 300,865            168,189  
  Stockholders’ equity                                                          
  Common stock                                           17                 17  
  Additional paid-in capital                      1,585,959          1,348,969  
  Accumulated other comprehensive                                               
  (loss)                                            -13,188              4,310  
  income                                                                        
  Retained earnings                                 426,680             10,338  
  Total stockholders’ equity                      1,999,468          1,363,634  
  Total liabilities and                                                         
  stockholders’                        $          2,300,333    $     1,531,823  
  equity                                                                        
                                                                                
                                                                                
                               ASTERA LABS, INC.                                
                                                                                
                                                                                
          CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)           
                                                                                
                    (In thousands, except per share amounts)                    
                                                                                
        Th…  Se…            J…            S…         N…  Se…           Se…      
        Mo…  30,            3…            3…         M…  30,           30,      
        En…  20…            2…            2…         E…  20…           20…      
 ────────────────────────────────────────────────────────────────────────────── 
  R…    $    58…         $  3…         $  2…         $   1,…        $  58…      
  C…                                                                            
  of         16…            1…            5…             34…           14…      
  r…                                                                            
  G…         42…            2…            1…             94…           44…      
  p…                                                                            
  O…                                                                            
  e…                                                                            
  R…                                                                            
  a…         17…            1…            7…             43…           21…      
  d…                                                                            
  S…                                                                            
  a…         37…            2…            1…             85…           59…      
  m…                                                                            
  G…                                                                            
  a…         35…            3…            2…             97…           64…      
  a…                                                                            
  T…                                                                            
  o…         24…            1…            1…             61…           33…      
  e…                                                                            
  O…         17…            8…            5…             33…           10…      
  i…                                                                            
  I…                                                                            
  a…         12…            1…            1…             38…           32…      
  o…                                                                            
  i…                                                                            
  I…                                                                            
  b…         19…            1…            6…             36…           13…      
  i…                                                                            
  t…                                                                            
  I…                                                                            
  t…         -9…            5…            2…             48…           34…      
  (…                                                                            
  b…                                                                            
  N…    $    18…         $  1…         $  9…         $   41…        $  17…      
  i…                                                                            
  N…                                                                            
  i…                                                                            
  p…                                                                            
  s…                                                                            
  B…    $    1.…         $  0…         $  0…         $   2.…        $  1.…      
  D…    $    0.…         $  0…         $  0…         $   2.…        $  0.…      
  W…                                                                            
  s…                                                                            
  u…                                                                            
  in                                                                            
  c…                                                                            
  n…                                                                            
  i…                                                                            
  p…                                                                            
  s…                                                                            
  B…              17…           17…           16…             1…            1…  
  D…              18…           18…           18…             1…            1…  
                                                                                
                                                                                
                               ASTERA LABS, INC.                                
                                                                                
          CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)           
                                                                                
                                 (In thousands)                                 
                                                                                
  Cash flows from                                                               
  operating              Nine Months Ended                                      
  activities             September 30,        2026              2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Net income                                  $      416,342    $      174,152  
  Adjustments to                                                                
  reconcile net                                                                 
  income to                                                                     
  net cash provided                                                             
  by operating                                                                  
  activities                                                                    
  Stock-based                                        195,495           118,659  
  compensation                                                                  
  Depreciation and                                    12,681             3,983  
  amortization                                                                  
  Warrants contra                                     30,397             4,016  
  revenue                                                                       
  Accretion of                                                                  
  discounts on                                        -3,426            -6,278  
  marketable                                                                    
  securities                                                                    
  Other, net                                           7,312             2,521  
  Changes in                                                                    
  operating assets                                                              
  and                                                                           
  liabilities:                                                                  
  Accounts                                          -201,245            -4,089  
  receivable, net                                                               
  Inventory                                         -146,173            -7,106  
  Prepaid expenses                                   -51,767           -56,760  
  and other assets                                                              
  Accounts payable                                    38,814            -1,088  
  Accrued expenses                                                              
  and other                                           43,047            -3,969  
  liabilities                                                                   
  Net cash provided                                                             
  by operating                                       341,477           224,041  
  activities                                                                    
  Cash flows from                                                               
  investing                                                                     
  activities                                                                    
  Purchases of                                                                  
  property and                                       -73,363           -18,855  
  equipment                                                                     
  Purchases of                                                                  
  marketable                                        -509,927          -664,432  
  securities                                                                    
  Sales and                                                                     
  maturities of                                      348,213           515,109  
  marketable                                                                    
  securities                                                                    
  Payments for                                                                  
  business                                           -69,214                 —  
  combinations, net                                                             
  of cash acquired                                                              
  Other investing                                     -2,500              -500  
  activities                                                                    
  Net cash used in                                                              
  investing                                         -306,791          -168,678  
  activities                                                                    
  Cash flows from                                                               
  financing                                                                     
  activities                                                                    
  Proceeds from                                                                 
  exercises of stock                                     802             1,730  
  options                                                                       
  Proceeds from                                                                 
  employee stock                                       6,294             4,345  
  purchase                                                                      
  plan                                                                          
  Net cash provided                                                             
  by financing                                         7,096             6,075  
  activities                                                                    
  Net increase in                                                               
  cash, cash                                          41,782            61,438  
  equivalents,                                                                  
  and restricted cash                                                           
  Cash, cash                                                                    
  equivalents, and                                                              
  restricted                                                                    
  cash                                                                          
  Beginning of the                                   167,684            80,044  
  period                                                                        
  End of the period                           $      209,466    $      141,482  
                                                                                
                                                                                
                               ASTERA LABS, INC.                                
                                                                                
       RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited)        
                                                                                
            (In thousands, except percentages and per share amounts)            
                                                                                
         Thr…  Sep…          Ju…          Sep…       Ni…  Sep…          Se…     
         Mon…   30,          30,           30,       Mo…   30,          30,     
         End…  2026          20…          2025       En…  2026          20…     
 ────────────────────────────────────────────────────────────────────────────── 
  GA…                                                                           
  gr…    $     422…       $  28…       $  175…       $    945…       $  44…     
  pr…                                                                           
  St…                                                                           
  co…           890          1,…           379            3,0…          694     
  ex…                                                                           
  No…                                                                           
  gr…    $     423…       $  28…       $  176…       $    948…       $  44…     
  pr…                                                                           
  GA…                                                                           
  gr…          72.3  %       73…  %       76.2  %         73.5  %       75…  %  
  ma…                                                                           
  St…                                                                           
  co…           0.2          0.4           0.2             0.2          0.1     
  ex…                                                                           
  No…                                                                           
  gr…          72.4  %       73…  %       76.4  %         73.8  %       75…  %  
  ma…                                                                           
  GA…                                                                           
  op…    $     179…       $  89…       $  55,…       $    330…       $  10…     
  in…                                                                           
  St…                                                                           
  co…          82,…          63…          40,…            195…          11…     
  ex…                                                                           
  Ac…             —          232             —            1,2…            —     
  co…                                                                           
  No…                                                                           
  op…    $     261…       $  15…       $  96,…       $    526…       $  22…     
  in…                                                                           
  GA…                                                                           
  op…          30.6  %       22…  %       24.0  %         25.7  %       18…  %  
  ma…                                                                           
  St…                                                                           
  co…          14.1          16…          17.7            15.2          20…     
  ex…                                                                           
  Ac…             —          0.1             —             0.1            —     
  co…                                                                           
  No…                                                                           
  op…          44.7  %       39…  %       41.7  %         41.0  %       38…  %  
  ma…                                                                           
  GA…                                                                           
  net    $     182…       $  15…       $  91,…       $    416…       $  17…     
  in…                                                                           
  St…                                                                           
  co…          82,…          63…          40,…            195…          11…     
  ex…                                                                           
  Ac…             —          232             —            1,2…            —     
  co…                                                                           
  Ot…             —          -1…             —            -1,…            —     
  In…                                                                           
  tax          -22…          -6…          -43…            -11…          -6…     
  ef…                                                                           
  No…                                                                           
  net    $     243…       $  14…       $  88,…       $    499…       $  22…     
  in…                                                                           
  Net                                                                           
  in…                                                                           
  per                                                                           
  sh…                                                                           
  at…                                                                           
  to                                                                            
  co…                                                                           
  st…                                                                           
  GA…                                                                           
  -      $     1.05       $  0.…       $  0.54       $    2.41       $  1.…     
  ba…                                                                           
  GA…                                                                           
  -      $     0.99       $  0.…       $  0.50       $    2.28       $  0.…     
  di…                                                                           
  No…                                                                           
  -      $     1.32       $  0.…       $  0.49       $    2.73       $  1.…     
  di…                                                                           
  We…                                                                           
  av…                                                                           
  sh…                                                                           
  us…                                                                           
  to                                                                            
  co…                                                                           
  net                                                                           
  in…                                                                           
  per                                                                           
  sh…                                                                           
  at…                                                                           
  to                                                                            
  co…                                                                           
  st…                                                                           
  GA…                                                                           
  -            174…          17…          167…            172…          16…     
  ba…                                                                           
  GA…                                                                           
  -            184…          18…          180…            182…          17…     
  di…                                                                           
                                                                                
____________________
(1) Total may not sum due to rounding.

(2 ) Acquisition-related costs included certain incremental expenses incurred to
effect a business combination such as third-party costs: advisory, legal,
accounting, valuation, and other professional fees.

(3) Other included non-cash and nonrecurring fair value adjustments on equity
investments without readily determinable fair values.

(4) Income tax effect is calculated based on the tax laws in the jurisdictions
in which we operate and is calculated to exclude the impact of stock-based
compensation expense and one-off discrete tax adjustments that are unrelated to
our core operating performance. For the three months ended September 30, 2026,
June 30, 2026, and September 30, 2025, the non-GAAP tax rate was approximately
11%, 12%, and 18%, respectively. For the nine months ended September, 2026 and
2025, the non-GAAP tax rate was approximately 11% and 12%, respectively.
                                                                                
                               ASTERA LABS, INC.                                
                                                                                
             RECONCILIATION OF GAAP TO NON-GAAP OUTLOOK (Unaudited)             
                                                                                
            (In millions, except percentages and per share amounts)             
                                                                                
                            Outlook for Three Months                            
                            Ending                                              
                            December 31, 2026                                   
 ────────────────────────────────────────────────────────────────────────────── 
                            Low                                  High           
  GAAP gross margin                                     72  %            72  %  
  Stock-basedcompensati…                                 —                —     
  Non-GAAP gross margin                                 72  %            72  %  
  GAAP operating            $                          273       $      279     
  expenses                                                                      
  Stock-based                                          -79              -79     
  compensation expense                                                          
  Non-GAAP operating        $                          194       $      200     
  expenses                                                                      
  GAAP tax rate                                         20  %            20  %  
  Income tax effect                                     -8               -8     
  Non-GAAP tax rate                                     12  %            12  %  
  GAAP net income per       $                         1.13       $     1.17     
  share - diluted                                                               
  Stock-based                                         0.43             0.43     
  compensation expense                                                          
  Income tax effect                                   0.06             0.06     
  Non-GAAP net income       $                         1.62       $     1.66     
  per share - diluted                                                           
                                                                                
                                                                                
                               ASTERA LABS, INC.                                
                                                                                
                                                                                
                       SUPPLEMENTAL FINANCIAL INFORMATION                       
                                                                                
                                                                                
                  STOCK-BASED COMPENSATION EXPENSE (Unaudited)                  
                                                                                
                                 (In thousands)                                 
                                                                                
           Three  Septe…        June       Septe…    Nine   Septe…       Sept…  
           Mont…     30,         30,          30,    Mont…     30,         30,  
           Ended    2026        2026         2025    Ended    2026        2025  
 ────────────────────────────────────────────────────────────────────────────── 
  Cost                                                                          
  of       $         890    $  1,692    $     379    $       3,081    $    694  
  reve…                                                                         
  Rese…                                                                         
  and             49,395       36,4…       21,711           115,2…       58,7…  
  deve…                                                                         
  Sales                                                                         
  and             19,678       11,4…        9,361           40,989       30,8…  
  mark…                                                                         
  Gene…                                                                         
  and             12,627       14,4…        9,288           36,213       28,3…  
  admi…                                                                         
  Total                                                                         
  stoc…    $      82,590    $  63,9…    $  40,739    $      195,4…    $  118,…  
  comp…                                                                         
  expe…                                                                         
                                                                                

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ALAB/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.